Abstract:Corneal blindness accounts for 5.1% of visual deficiency and is the fourth leading cause of blindness globally. An additional 1.5–2 million people develop corneal blindness each year, including many children born with or who later develop corneal infections. Over 90% of corneal blind people globally live in low- and middle-income regions (LMIRs), where corneal ulcers are approximately 10-fold higher compared to high-income countries. While corneal transplantation is an effective option for patients in high-income countries, there is a considerable global shortage of corneal graft tissue and limited corneal transplant programs in many LMIRs. In situ tissue regeneration aims to restore diseases or damaged tissues by inducing organ regeneration. This can be achieved in the cornea using biomaterials based on extracellular matrix (ECM) components like collagen, hyaluronic acid, and silk. Solid corneal implants based on recombinant human collagen type III were successfully implanted into patients resulting in regeneration of the corneal epithelium, stroma, and sub-basal nerve plexus. As ECM crosslinking and manufacturing methods improve, the focus of biomaterial development has shifted to injectable, in situ gelling formulations. Collagen, collagen-mimetic, and gelatin-based in situ gelling formulas have shown the ability to repair corneal wounds, surgical incisions, and perforations in in-vivo models. Biomaterial approaches may not be sufficient to treat inflammatory conditions, so other cell-free therapies such as treatment with tolerogenic exosomes and extracellular vesicles may improve treatment outcomes. Overall, many of the technologies described here show promise as future medical devices or combination products with cell or drug-based therapies. In situ tissue regeneration, particularly with liquid formulas, offers the ability to triage and treat corneal injuries and disease with a single regenerative solution, providing alternatives to organ transplantation and improving patient outcomes.

Acquisition of an Unknown Hopping Code in an Ultra-Wideband FH-OFDM System

Single-Cell RNA-Sequencing Reveals the Transcriptional Landscape of Lacrimal Gland in GVHD Mouse Model

Challenges and Strategies for Regenerating the Lacrimal Gland

EARTH STRUCTURE AND EARTH ORIGIN.

Development of Causative Treatment Strategies for Lacrimal Gland Insufficiency by Tissue Engineering and Cell Therapy. Part 1: Regeneration of Lacrimal Gland Tissue: Can We Stimulate Lacrimal Gland Renewal In Vivo?

Characterization of a new lacrimal gland cell line in 2D and 3D cell culture models

Advanced Biomaterials for Lacrimal Tissue Engineering: A Review

A New Immortalized Human Lacrimal Gland Cell Line

Three Dimensional Culture of Potential Epithelial Progenitor Cells in Human Lacrimal Gland

Distinctive small molecules blend: Promotes lacrimal gland epithelial cell proliferation in vitro and accelerates lacrimal gland injury repair in vivo

New experimental method to study acid/base transporters and their regulation in lacrimal gland ductal epithelia

Enhancement of lacrimal gland cell function by decellularized lacrimal gland derived hydrogel

A Single-Cell RNA-Sequencing Atlas

Thin-tapered-rod Yb:YAG laser amplifier.

Analysis of the heterogeneity and complexity of murine extraorbital lacrimal gland via single-cell RNA sequencing

The Potential Role of Exosomes in Ocular Surface and Lacrimal Gland Regeneration

Unveiling senescence-associated ocular pathogenesis via lacrimal gland organoid magnetic bioassembly platform and HMGB1-Box A gene therapy

Building a Functional Salivary Gland for Cell-Based Therapy: More than Secretory Epithelial Acini

In situ Tissue Regeneration in the Cornea from Bench to Bedside

[Regenerative medicine for the corneal epithelium : Cell therapy from bench to bedside]

Development of a presynaptic 5-HT1A antagonist.